Records containing: Neoplasms, Glandular and Epithelial
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
-
CLINICAL_TRIALS study record update · 2026-04-13Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
-
CLINICAL_TRIALS study record update · 2025-12-31Quality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National Trial
-
CLINICAL_TRIALS study record update · 2025-12-15Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
-
CLINICAL_TRIALS study record update · 2025-11-12A Phase 2 Trial to Evaluate the Safety and Efficacy of NKT2152 in Combination With Palbociclib (Doublet) and With Palbociclib and Sasanlimab (Triplet) in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-29Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
-
CLINICAL_TRIALS study record update · 2025-07-30An Open-label Phase 1 Study to Evaluate the Safety and Efficacy of AB-1015 in Patients With Resistant/Refractory Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-05-31A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-11-05The Expanded Access Use of Vorasidenib in Patients With IDH1 or IDH2 Mutated Glioma
-
CLINICAL_TRIALS study record update · 2024-07-03A Prospective, Single-arm, Multicenter, Exploratory Phase II Study to Evaluate the Efficacy and Safety of Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-06-08A Phase II, Open Lable, Single Arm, Trial to Determine Efficacy and Safety of Lenvatinib in Combination With Pembrolizumab for Platinum- Sensitive Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-03-23A Phase I, Escalating Dose Study of VB6-845, a Recombinant Fusion Protein Targeting EpCAM, in Patients With Advanced Solid Tumours of Epithelial Origin
-
CLINICAL_TRIALS study record update · 2022-07-06Efficacy of the Oncoxin-Viusid® Nutritional Supplement on the Quality of Life of Patients With Advanced or Metastatic Ovarian Epithelial Cancer. Clinical Trial Phase II.
-
CLINICAL_TRIALS study record update · 2022-04-28A Phase 1 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-03-08Specific Use Results Survey of LENVIMA 4 mg Capsules -Observational Study of Overall Survival in Patients With Unresectable Hepatocellular Carcinoma (Study LEN03T)
-
CLINICAL_TRIALS study record update · 2022-01-25A Phase 1, Randomized, Open-Label, Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (SNDX-275-0141, MK3475-460/KEYNOTE-460)
-
CLINICAL_TRIALS study record update · 2022-01-18Hepatic Resection Versus Radiofrequency Ablation for Patients With Hepatocellular Carcinoma and Portal Hypertension
-
CLINICAL_TRIALS study record update · 2021-05-05Intended Use Study of the BD SurePath Plus™ Pap
-
CLINICAL_TRIALS study record update · 2020-11-10A Single-arm, Prospective, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2020-10-30A Prospective, Single-arm, Single-center, Exploratory Phase II Study to Evaluate the Efficacy and Safety of Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2018-10-24A Phase II Study of Ixabepilone Prior to Surgery for High-risk Localized Prostate Cancer
-
CLINICAL_TRIALS study record update · 2018-09-18The Low Rectal Cancer Study.
-
CLINICAL_TRIALS study record update · 2018-09-17Is Greater Downstaging and Tumour Regression Observed When Surgery is Delayed to 12 Weeks After Completion of Chemoradiotherapy vs 6 Weeks?
-
CLINICAL_TRIALS study record update · 2018-09-14Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer
-
CLINICAL_TRIALS study record update · 2018-09-06BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities